Skip to main content
Log in

Trends in laryngopharyngeal reflux: a British ENT survey

  • Laryngology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

There is a lot of scepticism surrounding laryngopharyngeal reflux (LPR). Symptoms such as globus pharyngeus, constant throat clearing, chronic cough, idiopathic hoarseness, catarrh and choking episodes may be reflux-related. The aim of this survey was to highlight current treatment trends in LPR. Questionnaires were emailed to 260 members of the British Academy of Otolaryngology-Head and Neck surgery (BAO-HNS). Survey recipients were asked about type, duration and dose of antireflux treatment and length of follow-up appointments, if any. Finally, they were asked about awareness of any reflux symptom and reflux sign questionnaires. Survey response rate was 60%. The vast majority of the otolaryngologists surveyed believe in laryngopharyngeal reflux (90%) and more than 50% prescribe proton pump inhibitors (PPIs). The preferred duration of treatment is 2 months (37%). Only a minority will prescribe PPIs for 6 months or more. Most otolaryngologists will give the standard GORD dose (70%) (once daily) and only a few (20%) will prescribe more aggressive and prolonged doses. The commonest symptoms for which proton pump inhibitors are prescribed are globus (73%), followed by choking episodes (66%) and chronic cough (62%). If LPR is suspected, most of the otolaryngologists will follow-up the patients (61%) and approximately one third (31%) will discharge them back to the general practitioners. Only eight-percent 8% will refer to gastroenterologists. The three commonest laryngoscopic signs that makes them suspect LPR are erythema of the arytenoids (86%) or the vocal cords (57%) and granulomas (42%). The majority of the otolaryngologists (94%) do not use popular questionnaires such as the RFS or RSI. Despite the controversy surrounding laryngopharyngeal reflux, our results suggest that the majority of the otolaryngologists surveyed believe in LPR and attempt to treat it. Interesting findings are: the duration of treatment, the doses used, the length of follow-ups or the lack of, and the fact that the majority does not request any specific diagnostic tests. “symptoms and signs” questionnaires are rarely used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Koufman JA (1991) The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101(Suppl 53):1–78

    PubMed  CAS  Google Scholar 

  2. Karkos PD, Wilson JA (2006) Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 116:144–147

    Article  PubMed  CAS  Google Scholar 

  3. Office of Health Economics (1996) Health expenditures in the UK. Stationery Office, London

  4. Karkos PD, Thomas L, Temple RH, Issing WJ (2005) Awareness of general practitioners towards treatment of laryngopharyngeal reflux: a British survey. Otolaryngol Head Neck Surg 133(4):505–508

    Article  PubMed  CAS  Google Scholar 

  5. Knight J, Lively MO, Johnston N, Dettmar PW, Koufman JA (2005) Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux. Laryngoscope 115:1473–1478

    Article  PubMed  CAS  Google Scholar 

  6. Little JP, Matthews BL, Glock MS, Koufman JA, Reboussin DM, Loughlin CJ, McGuirt WF Jr (1997) Extraesophageal pediatric reflux: 24-hour double-probe pH monitoring of 222 children. Ann Otol Rhinol Laryngol Suppl 169:1–16

    PubMed  CAS  Google Scholar 

  7. Senders CW (2006) Should otolaryngologists perform pH probe studies? Curr Opin Otolaryngol Head Neck Surg 14(1):38–40

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. D. Karkos.

Appendix

Appendix

Do you “believe” in Laryngopharyngeal Reflux

  • Yes

  • No

  • I am not familiar with this term

How often do you prescribe antireflux treatment (including Proton Pump inhibitors-PPIs) in outpatients?

  • Never

  • <10% of cases

  • 10–49%

  • >50% of cases

If you suspect Laryngopharyngeal Reflux, what is your next action?

  • Refer back to the GP with advice

  • Refer to a gastroenterologist and/or order investigations

  • Start them on antireflux treatment and follow them up

What is the commonest symptom (apart from indigestion) you prescribe PPIs for? You can tick one, or more from the following:

  • Feeling of something stuck in the throat (globus pharyngeus)

  • Frequent throat clearing

  • Halitosis, bitter taste in the mouth

  • Hoarseness

  • Chronic cough

  • Catarrh

  • Dysphagia

  • Choking episodes, esp when lying down

  • Wheezing and “asthma-like” symptoms

What is the sign or signs on Fibreoptic Laryngoscopy that makes you suspect LPR?

  • Erythema of arytenoids

  • Erytthema of vocal cords

  • Diffuse laryngeal oedema

  • Vocal cord oedema

  • Infraglottic oedema

  • Laryngeal granulomas

  • Thick laryngeal mucous

How long do you prescribe PPIs for?

  • 1/12

  • 2/12

  • 3/12

  • 6/12

  • >6/12

Do you give PPIs once or twice daily?

  • Once

  • Twice

Do you advice your patients about life-style modifications, i.e. smoking, spicy food, late meals, etc.?

  • Yes

  • No

Do you give PPIs at night or daytime or both?

  • Night

  • Daytime

  • Both

Are you familiar with the reflux finding score and Reflux Symptom Index?

  • Yes

  • No

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karkos, P.D., Benton, J., Leong, S.C. et al. Trends in laryngopharyngeal reflux: a British ENT survey. Eur Arch Otorhinolaryngol 264, 513–517 (2007). https://doi.org/10.1007/s00405-006-0222-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-006-0222-8

Keywords

Navigation